All In MedTech

FDA Clearance Tracker · P140008-S028

ORBERA INTRAGASTRIC BALLOON

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 5, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 5, 2026

Approved

Time to decision

46 days

Received Nov 20, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140008-S028
Device name
ORBERA INTRAGASTRIC BALLOON
Applicant location
Marlboro, MA
Received
Nov 20, 2025
Decided
Jan 5, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P140008

Device type

Device class
Class III

Every decision under product code LTI

FDA's approval statement

As written in FDA's record.

a manufacturing site change to replace the Apollo Endosurgery Coyol, Costa Rica facility with the Boston Scientific Coyol, Costa Rica facility for the Orbera Intragastric Balloon, following acquisition of Apollo Endosurgery by Boston Scientific

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.